Dietary restrictions in dialysis patients: is there anything left to eat?
K Kalantar‐Zadeh, AR Tortorici, JLT Chen… - Seminars in …, 2015 - Wiley Online Library
A significant number of dietary restrictions are imposed traditionally and uniformly on
maintenance dialysis patients, whereas there is very little data to support their benefits …
maintenance dialysis patients, whereas there is very little data to support their benefits …
Haemodialysis-induced hypoglycaemia and glycaemic disarrays
M Abe, K Kalantar-Zadeh - Nature Reviews Nephrology, 2015 - nature.com
In patients with diabetes receiving chronic haemodialysis, both very high and low glucose
levels are associated with poor outcomes, including mortality. Conditions that are associated …
levels are associated with poor outcomes, including mortality. Conditions that are associated …
[HTML][HTML] Nutrition intervention for advanced stages of diabetic kidney disease
J Goldstein-Fuchs, K Kalantar-Zadeh - Diabetes spectrum: a …, 2015 - ncbi.nlm.nih.gov
IN BRIEF For the goals of reducing diabetic kidney disease (DKD) onset and progression,
approaches to nutritional therapy are a subject of much debate. This article discusses …
approaches to nutritional therapy are a subject of much debate. This article discusses …
Relaxin inhibits high glucose-induced matrix accumulation in human mesangial cells by interfering with TGF-β1 production and mesangial cells phenotypic transition
X Xie, W Xia, X Fei, Q Xu, X Yang, D Qiu… - Biological and …, 2015 - jstage.jst.go.jp
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD). DN is
characterized by glomerular extracellular matrix accumulation, mesangial expansion …
characterized by glomerular extracellular matrix accumulation, mesangial expansion …
[HTML][HTML] Cross-sectional examination of metabolites and metabolic phenotypes in uremia
Background Although metabolomic approaches have begun to document numerous
changes that arise in end stage renal disease (ESRD), how these alterations relate to …
changes that arise in end stage renal disease (ESRD), how these alterations relate to …
[PDF][PDF] Metformin in chronic kidney disease: more harm than help?
K Kalantar-Zadeh, CM Rhee - The Lancet Diabetes and …, 2015 - escholarship.org
Drug regulatory agencies in countries around the world have issued specific warnings and
restrictions pertaining to the use of metformin in patients with chronic kidney disease (CKD) …
restrictions pertaining to the use of metformin in patients with chronic kidney disease (CKD) …
[HTML][HTML] Взаимосвязь вариабельности уровня глюкозы и функции почек у больных сахарным диабетом 2 типа на базис-болюсной инсулинотерапии
ВВ Климонтов, НЕ Мякина - Сахарный диабет, 2015 - cyberleninka.ru
Цель. Определить взаимосвязь вариабельности уровня глюкозы (ВГ) с функцией почек
у больных сахарным диабетом 2 типа (СД2), получающих базис-болюсную …
у больных сахарным диабетом 2 типа (СД2), получающих базис-болюсную …
Restricting metformin in CKD: continued caution warranted
CM Rhee, K Kalantar-Zadeh - American Journal of Kidney Diseases, 2015 - ajkd.org
Given the low observed incidence of metformin-associated lactic acidosis (MALA) in a
systematic review of diabetic patients with and without CKD, 1 a commentary by Stanton 2 …
systematic review of diabetic patients with and without CKD, 1 a commentary by Stanton 2 …
Bicarbonate dialysis compared to hemodiafiltration on glycemic excursions in patients with end-stage renal disease with and without type 2 diabetes mellitus
G Derosa, C Libetta, P Esposito, I Borettaz… - Journal of Diabetes and …, 2015 - Elsevier
Aim To evaluate the effects on glycemic excursions during bicarbonate dialysis (BHD)
compared to hemodiafiltration (HDF) in type 2 diabetic or not diabetic patients affected by …
compared to hemodiafiltration (HDF) in type 2 diabetic or not diabetic patients affected by …
[HTML][HTML] The relationships between glucose variability and renal function in type 2 diabetes patients on basal-bolus insulin therapy
VV Klimontov, NE Myakina - Diabetes mellitus, 2015 - dia-endojournals.ru
Aim. To assess the relationship of glucose variability (GV) and renal function in patients with
type 2 diabetes on basal-bolus insulin therapy. Materials and methods. We observed 101 …
type 2 diabetes on basal-bolus insulin therapy. Materials and methods. We observed 101 …